Lilly
-
Financial Markets
Eli Lilly Stock Just Got Even Sweeter. Here’s Why It’s Worth Buying Now
According to a sneak peek of the data from one of Eli Lilly‘s (NYSE: LLY) late-stage clinical trials, the cardiometabolic…
Read More » -
Financial Markets
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Owning shares of pharmaceutical giant Eli Lilly (NYSE: LLY) has generally been a great idea over the past year. Lilly’s…
Read More » -
Entrepreneurship
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access to Novo…
Read More » -
Financial Markets
Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?
If you’re investing in a stock with a high valuation, you know that expectations are going to be high when…
Read More » -
Entrepreneurship
Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market
Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked…
Read More » -
Entrepreneurship
Lilly Ledbetter, an icon of the equal pay movement, dies at 86
Former President Barack Obama signed into law the Lilly Ledbetter Fair Pay Act, which gave workers the right to sue…
Read More » -
Politics
Lilly Ledbetter, icon in the battle for U.S. equal pay, dead at 86
Lilly Ledbetter, an former Alabama factory manager whose lawsuit against her employer made her an icon of the equal pay…
Read More » -
Financial Markets
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
In the pharmaceutical world, it’s never good for a company to stumble in a hot therapeutic area, especially if it…
Read More »
